BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29597332)

  • 1. Makaluvamine G from the Marine Sponge Zyzzia fuliginosa Inhibits Muscle nAChR by Binding at the Orthosteric and Allosteric Sites.
    Kudryavtsev DS; Spirova EN; Shelukhina IV; Son LV; Makarova YV; Utkina NK; Kasheverov IE; Tsetlin VI
    Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29597332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-competitive Inhibition of Nicotinic Acetylcholine Receptors by Ladybird Beetle Alkaloids.
    Leong RL; Xing H; Braekman JC; Kem WR
    Neurochem Res; 2015 Oct; 40(10):2078-86. PubMed ID: 25370792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another Look at Pyrroloiminoquinone Alkaloids-Perspectives on Their Therapeutic Potential from Known Structures and Semisynthetic Analogues.
    Lin S; McCauley EP; Lorig-Roach N; Tenney K; Naphen CN; Yang AM; Johnson TA; Hernadez T; Rattan R; Valeriote FA; Crews P
    Mar Drugs; 2017 Mar; 15(4):. PubMed ID: 28353633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marine natural products acting on the acetylcholine-binding protein and nicotinic receptors: from computer modeling to binding studies and electrophysiology.
    Kudryavtsev D; Makarieva T; Utkina N; Santalova E; Kryukova E; Methfessel C; Tsetlin V; Stonik V; Kasheverov I
    Mar Drugs; 2014 Mar; 12(4):1859-75. PubMed ID: 24686559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unified Synthesis and Biological Evaluation of Makaluvamine J and Its Analogs.
    Kiichi Y; Fukuoka K; Kitano A; Ishino K; Kotoku N
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38543025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine Macrocyclic Imines, Pinnatoxins A and G: Structural Determinants and Functional Properties to Distinguish Neuronal α7 from Muscle α1(2)βγδ nAChRs.
    Bourne Y; Sulzenbacher G; Radić Z; Aráoz R; Reynaud M; Benoit E; Zakarian A; Servent D; Molgó J; Taylor P; Marchot P
    Structure; 2015 Jun; 23(6):1106-15. PubMed ID: 26004441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discorhabdins and pyrroloiminoquinone-related alkaloids.
    Hu JF; Fan H; Xiong J; Wu SB
    Chem Rev; 2011 Sep; 111(9):5465-91. PubMed ID: 21688850
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point Mutations of Nicotinic Receptor α1 Subunit Reveal New Molecular Features of G153S Slow-Channel Myasthenia.
    Kudryavtsev D; Isaeva A; Barkova D; Spirova E; Mukhutdinova R; Kasheverov I; Tsetlin V
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counteracting desensitization of human α7-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning.
    Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
    Toxicol Lett; 2018 Sep; 293():149-156. PubMed ID: 29248576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Antioxidant Activity of the Marine Pyrroloiminoquinone Makaluvamines.
    Alonso E; Alvariño R; Leirós M; Tabudravu JN; Feussner K; Dam MA; Rateb ME; Jaspars M; Botana LM
    Mar Drugs; 2016 Oct; 14(11):. PubMed ID: 27801775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors.
    Mordvitsev DY; Polyak YL; Kuzmin DA; Levtsova OV; Tourleigh YV; Utkin YN; Shaitan KV; Tsetlin VI
    Comput Biol Chem; 2007 Apr; 31(2):72-81. PubMed ID: 17392029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminobenzisoxazole compounds as agonists of α7 nicotinic acetylcholine receptors: a patent evaluation (WO 2017027600).
    He Y; Shen J
    Expert Opin Ther Pat; 2018 May; 28(5):429-436. PubMed ID: 29566578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dinoflagellate Toxin 20-Methyl Spirolide-G Potently Blocks Skeletal Muscle and Neuronal Nicotinic Acetylcholine Receptors.
    Couesnon A; Aráoz R; Iorga BI; Benoit E; Reynaud M; Servent D; Molgó J
    Toxins (Basel); 2016 Aug; 8(9):. PubMed ID: 27563924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptor.
    Wein T; Höfner G; Rappenglück S; Sichler S; Niessen KV; Seeger T; Worek F; Thiermann H; Wanner KT
    Toxicol Lett; 2018 Sep; 293():184-189. PubMed ID: 29097222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.
    Zlotos DP; Gündisch D; Ferraro S; Tilotta MC; Stiefl N; Baumann K
    Bioorg Med Chem; 2004 Dec; 12(23):6277-85. PubMed ID: 15519170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photo-induced covalent attachment of agonists as a tool to study allosteric mechanisms of nicotinic acetylcholine receptors.
    Mourot A; Kotzyba-Hibert F; Goeldner M; Bamberg E
    J Mol Neurosci; 2006; 30(1-2):3-4. PubMed ID: 17192602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.